Webinar: Communicating with People with Dementia – Holding Conversations Using the Example of Integrative Validation – with Sabine Seipp

Communicating effectively – but how? As already became clear in the last webinar with Prof. Gabriele Wilz, various barriers can arise when communicating with people with dementia. These hinder exchange and can thus strain the personal relationship with the affected person. Communication with people with dementia can be facilitated...

Communication with People with Dementia – General Guidelines and How to Handle Problematic Situations

Communication with other people is an essential part of our daily lives. However, various barriers arise when communicating with people with dementia, making exchange and related social participation more difficult. Misunderstanding, arguments, anger, and irritation, or even social withdrawal can be the consequences. In the lecture...

Webinar: Communication with People with Dementia – General Tips and Handling Problem Situations – with Prof. Dr. Gabriele Wilz

Communication with other people is an essential part of our daily lives. However, various barriers arise when communicating with people with dementia, making exchange and related social participation more difficult. Misunderstanding, arguments, anger, and irritation, or even social withdrawal can be the consequences. In the lecture...

Urban-rural differences in the diagnosis and treatment of dementia

Studies indicate differences in both the timing of diagnosis and the treatment of people with dementia between urban and rural regions. U.S. researchers wanted to find out how significant these differences are. The background of the study by Rahman and colleagues is that there are disparities in the availability, accessibility, and acceptance...

Controversy over new Alzheimer's drug

A new drug has been approved in the US, sparking a global controversy within Alzheimer's research. This is because 10 out of 11 reviewers rejected the drug for the treatment of Alzheimer's disease. The dementia group of the Cochrane Institute provides a brief overview of the evidence for Aducanumab. For a long time, there was...

Digital Health Applications (DiHAs)

Digital solutions in care? From 2022, digital care applications (DiPAs) are to be reimbursed by long-term care insurance funds, thus improving the care of the chronically ill and easing the daily routine of caring relatives. Especially in outpatient care settings, the use of digital solutions, such as apps or web-based applications, can offer a...